Paul Hudson, Sanofi CEO (via Getty)
April 6, 2022 02:01 PM EDT
Pharma

Fol­low­ing $1.9B buy­out, Sanofi shut­ters Kad­mon's NY site and chops 25 staffers

Nicole DeFeudis

Editor

Sanofi CEO Paul Hud­son is on a mis­sion to re­shape the com­pa­ny. Last year, that in­volved shelling out $1.9 bil­lion for Kad­mon and its new­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Some FDA med­ical de­vice staff re­in­stat­ed just days af­ter re­ceiv­ing pink slips

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Al­con tried to sink Au­ri­on's IPO in 'Valen­tine's Day mas­sacre,' new law­suits say

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times